Annual Accounts Receivable
$39.66 M
+$26.88 M+210.48%
December 31, 2023
Summary
- As of February 7, 2025, ASND annual accounts receivable is $39.66 million, with the most recent change of +$26.88 million (+210.48%) on December 31, 2023.
- During the last 3 years, ASND annual accounts receivable has risen by +$39.18 million (+8230.90%).
- ASND annual accounts receivable is now at all-time high.
Performance
ASND Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$36.97 M
-$15.73 M-29.85%
September 30, 2024
Summary
- As of February 7, 2025, ASND quarterly accounts receivable is $36.97 million, with the most recent change of -$15.73 million (-29.85%) on September 30, 2024.
- Over the past year, ASND quarterly accounts receivable has increased by +$8.61 million (+30.34%).
- ASND quarterly accounts receivable is now -29.85% below its all-time high of $52.70 million, reached on June 30, 2024.
Performance
ASND Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ASND Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +210.5% | +30.3% |
| 3 y3 years | +8230.9% | +5879.8% |
| 5 y5 years | +10000.0% | +100.0% |
ASND Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1492.0% | -29.9% | +1384.1% |
| 5 y | 5-year | at high | +8230.9% | -29.9% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -29.9% | -100.0% |
Ascendis Pharma A/S Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.97 M(-29.9%) |
| Jun 2024 | - | $52.70 M(+18.8%) |
| Mar 2024 | - | $44.38 M(+11.9%) |
| Dec 2023 | $39.66 M(+210.5%) | $39.66 M(+39.8%) |
| Sep 2023 | - | $28.36 M(+29.1%) |
| Jun 2023 | - | $21.97 M(+25.0%) |
| Mar 2023 | - | $17.58 M(+37.6%) |
| Dec 2022 | $12.77 M(+412.8%) | $12.77 M(+95.3%) |
| Sep 2022 | - | $6.54 M(+43.3%) |
| Jun 2022 | - | $4.56 M(-29.6%) |
| Mar 2022 | - | $6.48 M(+160.2%) |
| Dec 2021 | $2.49 M(+423.3%) | $2.49 M(+302.9%) |
| Sep 2021 | - | $618.20 K(+31.8%) |
| Jun 2021 | - | $468.90 K(+567.0%) |
| Mar 2021 | - | $70.30 K(-85.2%) |
| Dec 2020 | $476.00 K(-47.1%) | $476.00 K(-85.1%) |
| Sep 2020 | - | $3.20 M(+254.9%) |
| Dec 2019 | $900.60 K(>+9900.0%) | $900.60 K(>+9900.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(-100.0%) |
| Mar 2019 | - | $4500.00(-34.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $6900.00(-96.9%) | $6900.00(-71.7%) |
| Sep 2018 | - | $24.40 K(+23.9%) |
| Jun 2018 | - | $19.70 K(-53.0%) |
| Mar 2018 | - | $41.90 K(-81.4%) |
| Dec 2017 | $225.50 K(-25.7%) | $225.50 K(-56.9%) |
| Sep 2017 | - | $523.10 K(+1.6%) |
| Jun 2017 | - | $514.80 K(+27.5%) |
| Mar 2017 | - | $403.90 K(+33.1%) |
| Dec 2016 | $303.40 K(-73.9%) | $303.40 K(-35.5%) |
| Sep 2016 | - | $470.10 K(+7.8%) |
| Jun 2016 | - | $436.00 K(-56.7%) |
| Mar 2016 | - | $1.01 M(-13.5%) |
| Dec 2015 | $1.16 M(-26.0%) | $1.16 M(+40.3%) |
| Sep 2015 | - | $829.30 K(-45.1%) |
| Jun 2015 | - | $1.51 M(+64.2%) |
| Mar 2015 | - | $920.50 K(-41.4%) |
| Dec 2014 | $1.57 M(-33.3%) | $1.57 M(+6.0%) |
| Sep 2014 | - | $1.48 M(-37.0%) |
| Dec 2013 | $2.35 M(-68.9%) | $2.35 M |
| Dec 2012 | $7.56 M(+370.0%) | - |
| Dec 2011 | $1.61 M | - |
FAQ
- What is Ascendis Pharma A/S annual accounts receivable?
- What is the all time high annual accounts receivable for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual accounts receivable year-on-year change?
- What is Ascendis Pharma A/S quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly accounts receivable year-on-year change?
What is Ascendis Pharma A/S annual accounts receivable?
The current annual accounts receivable of ASND is $39.66 M
What is the all time high annual accounts receivable for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual accounts receivable is $39.66 M
What is Ascendis Pharma A/S annual accounts receivable year-on-year change?
Over the past year, ASND annual accounts receivable has changed by +$26.88 M (+210.48%)
What is Ascendis Pharma A/S quarterly accounts receivable?
The current quarterly accounts receivable of ASND is $36.97 M
What is the all time high quarterly accounts receivable for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly accounts receivable is $52.70 M
What is Ascendis Pharma A/S quarterly accounts receivable year-on-year change?
Over the past year, ASND quarterly accounts receivable has changed by +$8.61 M (+30.34%)